AU3014801A - Chelating compounds, their complexes with paramagnetic metals - Google Patents

Chelating compounds, their complexes with paramagnetic metals

Info

Publication number
AU3014801A
AU3014801A AU30148/01A AU3014801A AU3014801A AU 3014801 A AU3014801 A AU 3014801A AU 30148/01 A AU30148/01 A AU 30148/01A AU 3014801 A AU3014801 A AU 3014801A AU 3014801 A AU3014801 A AU 3014801A
Authority
AU
Australia
Prior art keywords
complexes
chelating compounds
paramagnetic metals
paramagnetic
metals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30148/01A
Other languages
English (en)
Inventor
Pier Lucio Anelli
Andrea Beltrami
Luisella Calabi
Maurizio Franzini
Alessandro Maiocchi
Kondareddiar Ramalingam
Ramachandran S. Ranganathan
Mario Virtuani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco SpA
Original Assignee
Bracco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco SpA filed Critical Bracco SpA
Publication of AU3014801A publication Critical patent/AU3014801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/93—MRI contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU30148/01A 1999-12-21 2000-12-20 Chelating compounds, their complexes with paramagnetic metals Abandoned AU3014801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI99A2656 1999-12-21
IT1999MI002656A IT1315263B1 (it) 1999-12-21 1999-12-21 Composti chelanti,loro chelati con ioni metallici paramagnetici, loropreparazione ed uso
PCT/EP2000/012977 WO2001046207A1 (en) 1999-12-21 2000-12-20 Chelating compounds, their complexes with paramagnetic metals

Publications (1)

Publication Number Publication Date
AU3014801A true AU3014801A (en) 2001-07-03

Family

ID=11384156

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30148/01A Abandoned AU3014801A (en) 1999-12-21 2000-12-20 Chelating compounds, their complexes with paramagnetic metals

Country Status (7)

Country Link
US (1) US6509324B1 (https=)
EP (1) EP1155023B1 (https=)
JP (1) JP2003518131A (https=)
AU (1) AU3014801A (https=)
DE (1) DE60018390T2 (https=)
IT (1) IT1315263B1 (https=)
WO (1) WO2001046207A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782996B2 (en) * 1999-12-23 2005-09-15 Basell Polyolefine Gmbh Transition metal compound, ligand system, catalyst system and the use of the latter for the polymerisation and copolymerisation of olefins
ITMI20011708A1 (it) * 2001-08-03 2003-02-03 Bracco Imaging Spa Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
FR2857967B1 (fr) * 2003-07-25 2015-04-24 Centre Nat Rech Scient Complexes de lanthanide, leur preparation et leurs utilisations
JP5106107B2 (ja) * 2004-07-02 2012-12-26 ブラッコ・イメージング・ソシエタ・ペル・アチオニ ポリヒドロキシル化置換基を有するキレート化部分を含む磁気共鳴画像法（ｍｒｉ）用高緩和能造影剤
US7795094B2 (en) * 2004-09-02 2010-09-14 Micron Technology, Inc. Recessed gate dielectric antifuse
EP1847555A1 (en) * 2006-04-18 2007-10-24 Borealis Technology Oy Multi-branched Polypropylene
WO2008073458A2 (en) 2006-12-11 2008-06-19 Bracco Imaging S.P.A. Fibrin-binding peptides and conjugates thereof
EP2476703A1 (en) 2011-01-14 2012-07-18 Bracco Imaging S.p.A Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
EP2147684A1 (en) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
WO2012095516A1 (en) 2011-01-14 2012-07-19 Bracco Imaging Spa Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
US10270465B2 (en) 2015-12-31 2019-04-23 International Business Machines Corporation Data compression in storage clients
US10015274B2 (en) 2015-12-31 2018-07-03 International Business Machines Corporation Enhanced storage clients
IL260957B2 (en) 2016-02-09 2023-11-01 Bracco Suisse Sa Chimeric, Recombinant Protein Glycoprotein Selectin-P Ligand-1 (PSGL-1) Conjugates, Preparations Containing Them and Uses Thereof
WO2017178301A1 (en) 2016-04-13 2017-10-19 Bracco Imaging Spa Contrast agents
CN110957532A (zh) * 2019-12-25 2020-04-03 惠州市豪鹏科技有限公司 锂离子电池用电解液及包含其的锂离子电池
CN113372384B (zh) * 2020-02-25 2022-10-11 广州平澜医疗科技有限公司 磁共振造影剂及其制备方法和应用
NL2030022B1 (en) * 2021-12-03 2023-06-21 Wisdom Pharmaceutical Co Ltd SYNTHESIS OF mRNA TRANSMITTER

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1392242A (en) * 1971-07-26 1975-04-30 Technic Process for producing by electrodeposition bright deposits of gold and its alloys
US4073700A (en) * 1975-03-10 1978-02-14 Weisberg Alfred M Process for producing by electrodeposition bright deposits of gold and its alloys
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US5039512A (en) * 1986-08-04 1991-08-13 Salutar, Inc. NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes
US5733528A (en) * 1993-12-03 1998-03-31 Dibra S.P.A. Paramagnetic chelates for nuclear magnetic resonance diagnosis
US6342598B1 (en) * 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents

Also Published As

Publication number Publication date
EP1155023B1 (en) 2005-03-02
US6509324B1 (en) 2003-01-21
ITMI992656A0 (it) 1999-12-21
IT1315263B1 (it) 2003-02-03
JP2003518131A (ja) 2003-06-03
WO2001046207A1 (en) 2001-06-28
DE60018390T2 (de) 2005-12-29
DE60018390D1 (de) 2005-04-07
US20030013859A1 (en) 2003-01-16
ITMI992656A1 (it) 2001-06-21
EP1155023A1 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
HUP0202442A3 (en) Multiple cytokine-antibody complexes
PL347324A1 (en) Bridged metal complexes
MXPA02003669A (es) Modificacion del tiempo de floracion.
AU3014801A (en) Chelating compounds, their complexes with paramagnetic metals
AU2002359373A1 (en) Alkene-platinum-silyl complexes
IL145839A0 (en) ESTROGEN RECEPTOR-β LIGANDS
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200108968B (en) New compounds.
MXPA03005433A (es) Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
AU3488700A (en) Luminescent metal-ligand complexes
AU2001240024A1 (en) Camptothecin complexes
AU5922200A (en) Metal hexacyanocobaltate nitroferricyanide complexes
GB0109758D0 (en) Mixed metal organic complexes
ZA200107421B (en) Complexing agents.
AU5984600A (en) Diphosphine ligands for metal complexes
AU2002210539A1 (en) Composition based on monofluoro metal complexes
AU4614699A (en) Water-soluble transition metal complexes
AU1332301A (en) Dicationic non-metallocene group 4 metal complexes
MXPA02005346A (es) Antigenos de cryptosporidium esporozoito.
AU2001220118A1 (en) Metal component carrier
GB9904740D0 (en) Metal complexes
ZA200201714B (en) Novel compound F-15078.
AU2001290910A1 (en) Bridged ylide group containing metal complexes
ZA996247B (en) Bridged metal complexes.
AU2002222387A1 (en) Cyclodextrin-drospirenone inclusion complexes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase